• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A群和C群脑膜炎球菌多糖疫苗对鼻咽部带菌状态的影响。

The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carrier state.

作者信息

Stroffolini T, Angelini L, Galanti I, Occhionero M, Congiu M E, Mastrantonio P

机构信息

Laboratorio di Epidemiologia, Istituto Superiore di Sanità, Roma, Italy.

出版信息

Microbiologica. 1990 Jul;13(3):225-9.

PMID:2125684
Abstract

The effect of Neisseria meningitidis group A and C polysaccharide vaccine on nasopharyngeal carriage was studied in Italian army recruits. Throat swabs were cultured for N. meningitidis at the time of vaccination (one week after entry to service) and again three weeks later in a follow-up cohort of 98 men. At the first survey the overall carriage rate was 32% with 9% of isolates due to serogroup C, none to serogroup A and 17% to serogroup Y. At the second survey the overall carriage rate reached 52% (P less than 0.01); no isolate belonged to serogroup A or C, while serogroup Y reached 40% (P less than 0.01). The cumulative carriage rate was 65%. Out of the 64 carriers during the whole study period, only 7 (11%) belonged to the same serogroup during the two different surveys. The vaccination appears to influence the carriage rate of meningococcal specific serogroups. The inhibition of serogroups A and C is, however, offset by an increased prevalence of meningococci belonging to serogroup Y.

摘要

在意大利新兵中研究了A群和C群脑膜炎奈瑟菌多糖疫苗对鼻咽部带菌情况的影响。在接种疫苗时(入伍一周后)采集咽喉拭子培养脑膜炎奈瑟菌,三周后在98名男性的随访队列中再次采集。在首次调查中,总体带菌率为32%,其中9%的分离株属于C群,无A群分离株,17%属于Y群。在第二次调查中,总体带菌率达到52%(P<0.01);无分离株属于A群或C群,而Y群达到40%(P<0.01)。累积带菌率为65%。在整个研究期间的64名带菌者中,只有7名(11%)在两次不同调查中属于同一血清群。疫苗接种似乎影响脑膜炎奈瑟菌特定血清群的带菌率。然而,A群和C群的抑制作用被Y群脑膜炎球菌患病率的增加所抵消。

相似文献

1
The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carrier state.A群和C群脑膜炎球菌多糖疫苗对鼻咽部带菌状态的影响。
Microbiologica. 1990 Jul;13(3):225-9.
2
Meningococcal carriage and vaccination in army recruits in Italy.意大利新兵中的脑膜炎球菌携带情况与疫苗接种
Boll Ist Sieroter Milan. 1990;69(1):357-9.
3
[The prevalence of nasopharyngeal Neisseria meningitidis carriage, serogroup distribution, and antibiotic resistance among healthy children in Cankaya municipality schools of Ankara province].[安卡拉省坎卡亚市学校健康儿童中鼻咽部脑膜炎奈瑟菌携带率、血清群分布及抗生素耐药性]
Mikrobiyol Bul. 2005 Oct;39(4):411-20.
4
The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey.土耳其青少年和青年人群中脑膜炎球菌携带情况、血清群分布及危险因素
Hum Vaccin Immunother. 2017 May 4;13(5):1182-1189. doi: 10.1080/21645515.2016.1268304. Epub 2017 Jan 31.
5
Neisseria meningitidis carriage during an outbreak of serogroup C disease.C群脑膜炎奈瑟菌疾病暴发期间的带菌情况
Clin Infect Dis. 2003 Nov 1;37(9):1183-8. doi: 10.1086/378743. Epub 2003 Oct 3.
6
Nasopharyngeal carriage of Neisseria meningitidis in general population and meningococcal disease.普通人群中脑膜炎奈瑟菌的鼻咽部携带情况与脑膜炎球菌病
J Commun Dis. 1990 Dec;22(4):264-8.
7
Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998.1964年至1998年美国军人中与不同血清群特异性成分疫苗常规使用相关的脑膜炎球菌病
Clin Infect Dis. 2002 Dec 1;35(11):1376-81. doi: 10.1086/344273. Epub 2002 Nov 5.
8
[Healthy meningococcal carriers in 1973 in Greece. Sensitivity of the isolated strains to minocycline, rifampicin and sulphadiazine (author's transl)].[1973年希腊的健康脑膜炎球菌携带者。分离菌株对米诺环素、利福平及磺胺嘧啶的敏感性(作者译)]
Zentralbl Bakteriol Orig A. 1975;230(2):159-71.
9
Young-adult carriers of Neisseria meningitidis in Puglia (Italy): will the pattern of circulating meningococci change following the introduction of meningococcal serogroup C conjugate vaccines?意大利普利亚地区脑膜炎奈瑟菌的年轻成人携带者:引入C群脑膜炎球菌结合疫苗后,流行的脑膜炎球菌模式会改变吗?
Hum Vaccin. 2010 Dec;6(12):1025-7. doi: 10.4161/hv.6.12.13145. Epub 2010 Dec 1.
10
A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria.在亚历山大港进行的A群脑膜炎球菌多糖疫苗的第二项对照现场试验。
Bull World Health Organ. 1977;55(6):645-51.

引用本文的文献

1
Prospects for vaccine prevention of meningococcal infection.脑膜炎球菌感染疫苗预防的前景。
Clin Microbiol Rev. 2006 Jan;19(1):142-64. doi: 10.1128/CMR.19.1.142-164.2006.
2
Meningococcal vaccines.脑膜炎球菌疫苗。
Paediatr Drugs. 2004;6(4):251-66. doi: 10.2165/00148581-200406040-00004.
3
Absence of Neisseria meningitidis W-135 electrophoretic Type 37 during the Hajj, 2002.2002年朝觐期间未出现脑膜炎奈瑟菌W-135血清群37型菌株。
Emerg Infect Dis. 2003 Jun;9(6):734-7. doi: 10.3201/eid0906.020725.
4
Development and evaluation of an improved mouse model of meningococcal colonization.改良的脑膜炎球菌定植小鼠模型的开发与评估
Infect Immun. 2003 Apr;71(4):1849-55. doi: 10.1128/IAI.71.4.1849-1855.2003.